KRAS and neoplasm: Independent studies demonstrated that oncogenic KRAS itself initiates the growth of non-invasive tumours in mouse models of lung cancer46, 47, implying that KRAS mutations may induce tumorigenesis, but might not be responsible for tumour metastasis, at least in some cases.